Babak Navi, M.D.
Babak Navi, MD, is a native New Yorker who received his medical degree from New York University, where he graduated with honors (Alpha Omega Alpha Society). He completed a residency in neurology at the Weill Cornell Medical Center and served as the Chief Resident in his final year. He then went on to complete a two-year fellowship in vascular neurology at the University of California, San Francisco, where he also became certified in comprehensive neurosonology. In 2011, Dr. Navi returned to New York to become the Director of the Stroke Center at New York-Presbyterian Hospital/Weill Cornell Medical Center and an Assistant Professor of Neurology.
Dr. Navi is an expert on the relationship between cancer and stroke. He has written numerous papers and book chapters on this topic, and is the co-principal investigator of the first randomized trial to compare different blood thinners for patients with cancer and stroke. Dr. Navi also has conducted research studies on cryptogenic stroke, physician prognostication in severe brain injury, cerebrovascular presentations of dizziness, and the role of statin therapy for stroke. His work has been published in high impact peer-reviewed journals, including JAMA, Neurology, Archives of Neurology, Critical Care Medicine, and Stroke. In addition, he is on the editorial board of the journal Neurohospitalist and is the Weill Cornell site principal investigator for the NIH-funded POINT trial.